Competitive Tech Slated to Present at the SeeThruEquity Winter Microcap Invester Conference

Competitive Technologies's picture
Printer-friendly versionPrinter-friendly versionPDF versionPDF version
Convene Midtown East
730 Third Avenue, NYC (bet. 45th and 46th Streets)
Thursday, February 6, 2014 at 1:30 PM EST

Fairfield, Conn. - (February 5, 2014) - Competitive Technologies, Inc., (OTCQX: CTTC)(CTI), the pain mitigation company, is slated to present at the SeeThruEquity Winter Microcap Investor Conference on Thursday, February 6, 2014, at 1:30 PM EST.

The one-day event will host ten, select microcap companies at the Convene Midtown East in New York City. CTI President & CEO Conrad Mir will present to investors and be available for one-on-one meetings during the conference.

About SeeThruEquity

SeeThruEquity ("STE") is an equity research and corporate access firm focused on companies with less than $1 billion in market capitalization. The research is not paid for and unbiased. STE does not conduct any investment banking or commission based business. STE is approved to contribute research to Thomson Reuters One (First Call), CapitalIQ, FactSet, and Zacks, and distribute its research to its database of opt-in investors. Company research estimates are also contributed to Thomson Estimates, the leading estimates platform on Wall Street.

About Competitive Technologies

Competitive Technologies Inc., the pain mitigation company, develops and commercializes innovative wound and pain management products and technologies. CTI is the licensed distributor of the non-invasive Calmare® pain therapy medical device, which incorporates the biophysical "Scrambler Therapy"® technology developed to treat neuropathic and cancer-derived pain.

Forward-Looking Statements

Certain statements contained in this press release are forward-looking statements that involve risks and uncertainties. The statements contained herein that are not purely historical are forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements deal with the Company's current plans, intentions, beliefs and expectations and statements of future economic performance. Forward-looking statements involve known and unknown risks and uncertainties that may cause the Company's actual results in future periods to differ materially from what is currently anticipated. Factors that could cause or contribute to such differences include those discussed from time to time in reports filed by the Company with the Securities and Exchange Commission. The Company cannot guarantee its future results, levels of activity, performance or achievements.

News Source : Competitive Tech Slated to Present at the SeeThruEquity Winter Microcap Invester Conference

Copy this html code to your website/blog to embed this press release.